Anna Stiehm

Circulating Tumor Cells as a Marker for Progression‐free Survival in Metastatic Castration‐naïve Prostate Cancer

A. Bjartell, Anna Linder, K. Welén, 2017, The Prostate.

The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells

A. Bjartell, M. Persson, M. Palominos, 2022, Translational oncology.

STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population

N. Maitland, A. Bjartell, J. Morote, 2017, Scientific Reports.

Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases

Mahmoud A. Bassal, D. Tenen, B. Wegiel, 2020, Cell reports.